- Home
- SCLXW vs SPTN Comparison
SCLXW vs SPTN Comparison
Compare SCLXW & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLXW
- SPTN
- Stock Information
- Founded
- SCLXW N/A
- SPTN 1917
- Country
- SCLXW United States
- SPTN United States
- Employees
- SCLXW 117
- SPTN N/A
- Industry
- SCLXW Biotechnology: Pharmaceutical Preparations
- SPTN Food Distributors
- Sector
- SCLXW Health Care
- SPTN Consumer Discretionary
- Exchange
- SCLXW Nasdaq
- SPTN Nasdaq
- Market Cap
- SCLXW N/A
- SPTN N/A
- IPO Year
- SCLXW N/A
- SPTN N/A
- Fundamental
- Price
- SCLXW $0.10
- SPTN $20.67
- Analyst Decision
- SCLXW
- SPTN Hold
- Analyst Count
- SCLXW 0
- SPTN 1
- Target Price
- SCLXW N/A
- SPTN $20.00
- AVG Volume (30 Days)
- SCLXW 4.0K
- SPTN 273.6K
- Earning Date
- SCLXW 03-07-2025
- SPTN 02-12-2025
- Dividend Yield
- SCLXW N/A
- SPTN 4.25%
- EPS Growth
- SCLXW N/A
- SPTN N/A
- EPS
- SCLXW N/A
- SPTN 0.01
- Revenue
- SCLXW $55,152,000.00
- SPTN $9,549,324,000.00
- Revenue This Year
- SCLXW N/A
- SPTN $5.82
- Revenue Next Year
- SCLXW N/A
- SPTN N/A
- P/E Ratio
- SCLXW N/A
- SPTN $2,339.78
- Revenue Growth
- SCLXW 22.02
- SPTN N/A
- 52 Week Low
- SCLXW $0.18
- SPTN $17.30
- 52 Week High
- SCLXW $0.18
- SPTN $23.00
- Technical
- Relative Strength Index (RSI)
- SCLXW N/A
- SPTN 58.01
- Support Level
- SCLXW N/A
- SPTN $19.75
- Resistance Level
- SCLXW N/A
- SPTN $20.66
- Average True Range (ATR)
- SCLXW 0.00
- SPTN 0.38
- MACD
- SCLXW 0.00
- SPTN -0.00
- Stochastic Oscillator
- SCLXW 0.00
- SPTN 91.89
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.